{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:11Z","timestamp":1787020151127,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project on the Technology Innovation Think Tank of the Fujian Provincial Association for Science and Technology","award":["FJKX-2024XKB049"],"award-info":[{"award-number":["FJKX-2024XKB049"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2024Y9623"],"award-info":[{"award-number":["2024Y9623"]}]},{"name":"Science and Technology Program of Fujian Province","award":["2025J011174"],"award-info":[{"award-number":["2025J011174"]}]},{"name":"Science and Technology Program of Fujian Province","award":["2025J011175"],"award-info":[{"award-number":["2025J011175"]}]},{"name":"Fujian Provincial Health and Medical Innovation Project","award":["2023CXA038"],"award-info":[{"award-number":["2023CXA038"]}]},{"name":"Fujian Provincial Young and Middle-aged Health Leading Talent Training Program","award":["2023-2839"],"award-info":[{"award-number":["2023-2839"]}]},{"name":"High-level Talent Program of Fujian Cancer Hospital","award":["2022YNG10"],"award-info":[{"award-number":["2022YNG10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04467-w","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:45:21Z","timestamp":1764729921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative efficacy of neoadjuvant imatinib therapy in gastric versus rectal gastrointestinal stromal tumors: a two-center retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Jin-hu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-ming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-chai","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-cheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zai-sheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"5","key":"4467_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41571-022-00606-4","volume":"19","author":"LR Klug","year":"2022","unstructured":"Klug LR, Khosroyani HM, Kent JD, Heinrich MC. New treatment strategies for advanced-stage gastrointestinal stromal tumours. Nat Rev Clin Oncol. 2022;19(5):328\u201341.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4467_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00000658-200001000-00008","volume":"231","author":"RP DeMatteo","year":"2000","unstructured":"DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51\u20138.","journal-title":"Ann Surg"},{"issue":"10","key":"4467_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.humpath.2008.06.025","volume":"39","author":"Heikki Joensuu","year":"2008","unstructured":"Joensuu Heikki. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39(10):1411\u20139.","journal-title":"Hum Pathol"},{"issue":"4","key":"4467_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ejso.2011.01.005","volume":"37","author":"J Li","year":"2011","unstructured":"Li J, Gong JF, Wu AW, et al. Post-operative Imatinib in patients with intermediate or high risk Gastrointestinal stromal tumor[J]. Eur J Surg Oncol. 2011;37(4):319\u201324.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"4467_CR5","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jama.2012.347","volume":"307","author":"H Joensuu","year":"2012","unstructured":"Joensuu H, Eriksson M, Sundby Hall K, et al. One vs three years of adjuvant Imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307(12):1265\u201372.","journal-title":"JAMA"},{"issue":"15","key":"4467_CR6","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1200\/JCO.2013.51.2046","volume":"32","author":"CL Corless","year":"2014","unstructured":"Corless CL, Ballman KV, Antonescu CR, et al. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014;32(15):1563\u201370.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4467_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/jso.21160","volume":"99","author":"BL Eisenberg","year":"2009","unstructured":"Eisenberg BL, Harris J, Blanke CD, et al. Phase II trial of neoadjuvant\/adjuvant Imatinib mesylate (IM) for advanced primary and metastatic\/recurrent operable Gastrointestinal stromal tumor (GIST): early results of RTOG 0132\/ACRIN 6665. J Surg Oncol. 2009;99(1):42\u20137.","journal-title":"J Surg Oncol"},{"issue":"4","key":"4467_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1245\/s10434-011-2190-5","volume":"19","author":"D Wang","year":"2012","unstructured":"Wang D, Zhang Q, Blanke CD, et al. Phase II trial of neoadjuvant\/adjuvant Imatinib mesylate for advanced primary and metastatic\/recurrent operable Gastrointestinal stromal tumors: long-term follow-up results of radiation therapy oncology group 0132. Ann Surg Oncol. 2012;19(4):1074\u201380.","journal-title":"Ann Surg Oncol"},{"key":"4467_CR9","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1245\/s10434-013-3013-7","volume":"20","author":"P Rutkowski","year":"2013","unstructured":"Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Sch\u00f6ffski P, Bauer S, et al. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20:2937\u201343. https:\/\/doi.org\/10.1245\/s10434-013-3013-7.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4467_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/bjc.2017.144","volume":"117","author":"Y Kurokawa","year":"2017","unstructured":"Kurokawa Y, Yang HK, Cho H, et al. Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach. Br J Cancer. 2017;117(1):25\u201332.","journal-title":"Br J Cancer"},{"key":"4467_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ijc.33536","volume":"149","author":"KE Marqueen","year":"2021","unstructured":"Marqueen KE, Moshier E, Buckstein M, Ang C. Neoadjuvant therapy for gastrointestinal stromal tumors: a propensity score-weighted analysis. Int J Cancer. 2021;149:177\u201385. https:\/\/doi.org\/10.1002\/ijc.33536.","journal-title":"Int J Cancer"},{"key":"4467_CR12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00261-018-1803-x","volume":"44","author":"S Ren","year":"2019","unstructured":"Ren S, Chen X, Wang J, Zhao R, Song L, Li H, et al. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography. Abdom Radiol. 2019;44:867\u201376. https:\/\/doi.org\/10.1007\/s00261-018-1803-x.","journal-title":"Abdom Radiol"},{"key":"4467_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","volume":"23","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70\u201383. https:\/\/doi.org\/10.1053\/j.semdp.2006.09.001.","journal-title":"Semin Diagn Pathol"},{"key":"4467_CR14","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1245\/s10434-007-9377-9","volume":"14","author":"P Rutkowski","year":"2007","unstructured":"Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Wo\u017aniak A, Limon J, et al. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol. 2007;14:2018\u201327. https:\/\/doi.org\/10.1245\/s10434-007-9377-9.","journal-title":"Ann Surg Oncol"},{"key":"4467_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"key":"4467_CR16","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1158\/1078-0432.CCR-04-2245","volume":"11","author":"CR Antonescu","year":"2005","unstructured":"Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, et al. Acquired resistance to Imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res. 2005;11:4182\u201390. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2245.","journal-title":"Clin Cancer Res"},{"key":"4467_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040586","author":"N Vassos","year":"2021","unstructured":"Vassos N, Jakob J, K\u00e4hler G, Reichardt P, Marx A, Dimitrakopoulou-Strauss A, et al. Preservation of organ function in locally advanced non-metastatic gastrointestinal stromal tumors (GIST) of the stomach by neoadjuvant imatinib therapy. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13040586.","journal-title":"Cancers (Basel)"},{"key":"4467_CR18","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.5858\/2006-130-1466-GSTROM","volume":"130","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466\u201378. https:\/\/doi.org\/10.5858\/2006-130-1466-GSTROM.","journal-title":"Arch Pathol Lab Med"},{"key":"4467_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10120-023-01406-0","volume":"26","author":"SH Kong","year":"2023","unstructured":"Kong SH, Kurokawa Y, Yook JH, Cho H, Kwon OK, Masuzawa T, et al. Long-term outcomes of a phase II study of neoadjuvant Imatinib in large gastrointestinal stromal tumors of the stomach. Gastric Cancer. 2023;26:775\u201387. https:\/\/doi.org\/10.1007\/s10120-023-01406-0.","journal-title":"Gastric Cancer"},{"key":"4467_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00254-5","volume":"7","author":"JY Blay","year":"2021","unstructured":"Blay JY, Kang YK, Nishida T, von Mehren M. Gastrointestinal stromal tumours. Nat Rev Dis Primers. 2021;7:22. https:\/\/doi.org\/10.1038\/s41572-021-00254-5.","journal-title":"Nat Rev Dis Primers"},{"key":"4467_CR21","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1158\/1078-0432.CCR-14-1677","volume":"20","author":"A Wozniak","year":"2014","unstructured":"Wozniak A, Rutkowski P, Sch\u00f6ffski P, Ray-Coquard I, Hostein I, Schildhaus HU, et al. Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a European multicenter analysis based on conticagist. Clin Cancer Res. 2014;20:6105\u201316. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1677.","journal-title":"Clin Cancer Res"},{"key":"4467_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.20517\/cdr.2024.101","volume":"7","author":"F Zeng","year":"2024","unstructured":"Zeng F, Cao J, Chen Y, Tang J, He Q, Liao S, et al. Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells. Cancer Drug Resist. 2024;7:44. https:\/\/doi.org\/10.20517\/cdr.2024.101.","journal-title":"Cancer Drug Resist"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04467-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04467-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:27:16Z","timestamp":1771939636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04467-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4467"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04467-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article was updated to amend a typographical error in affiliation 4.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Fujian Medical University Union Hospital (Approval No. 2025KY086) and the Ethics Committee of Fujian Cancer Hospital (Approval No. K2025-166-01). Given the retrospective nature of the study and the use of anonymized data, the requirement for informed consent was waived by both ethics committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}